Cargando…
Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review
BACKGROUND: This study evaluated efficacy and safety of intravenous subanesthetic doses of esketamine using an administration time of 10 minutes in patients with treatment-resistant depression and bipolar depression. METHODS: A retrospective chart review was conducted to identify patients who met th...
Autores principales: | Correia-Melo, Fernanda S, Argolo, Felipe C, Araújo-de-Freitas, Lucas, Leal, Gustavo Carneiro, Kapczinski, Flávio, Lacerda, Acioly Luiz, Quarantini, Lucas C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488770/ https://www.ncbi.nlm.nih.gov/pubmed/28790825 http://dx.doi.org/10.2147/NDT.S135623 |
Ejemplares similares
-
Intranasal esketamine and the dawn of precision psychiatry
por: Watts, Devon, et al.
Publicado: (2021) -
Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial
por: Caliman-Fontes, Ana Teresa, et al.
Publicado: (2023) -
Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020) -
Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial
por: Correia-Melo, Fernanda S., et al.
Publicado: (2018) -
S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression
por: Correia-Melo, Fernanda S., et al.
Publicado: (2017)